--- title: "Hong Kong's Misfit Stocks: Biotech Breakthroughs vs. Mechanical Grouping" type: "News" locale: "en" url: "https://longbridge.com/en/news/302535049.md" description: "Nine firms in HKEX's \\\"Other\\\" sector reveal stark contrasts: 1541.HK's biotech leap, 0142.HK's infrastructure play, and 1901.HK's travel rebound versus 3848.HK's decline. Classification flaws exposed by mechanical grouping of unrelated businesses." datetime: "2026-10-21T09:17:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/302535049.md) - [en](https://longbridge.com/en/news/302535049.md) - [zh-HK](https://longbridge.com/zh-HK/news/302535049.md) generator: "portal-rs" --- # Hong Kong's Misfit Stocks: Biotech Breakthroughs vs. Mechanical Grouping Hong Kong's catch-all \\"Other\\" sector has become a mirror for market taxonomy flaws. 1541.HK's IMM0306 lymphoma therapy showed 92.3% ORR in MZL patients, outpacing sector peers. Meanwhile, 0142.HK boosted its stake in Philippine power giant Meralco to 49.4%, signaling strategic consolidation. Yet 1661.HK's event management revenue surged 186% year-on-year but faces sustainability questions, while 2360.HK's retail growth stalled amid consumer caution. The sector's oddities include 3179.HK's dormant ETH ETF and 8021.HK's scaffolding-to-lending pivot. Notably, 1901.HK's tour package revenue jumped 32% as travel rebounds, contrasting with 2177.HK's cross-border B2B growth offsetting domestic declines. Analysts note that 3848.HK's three-year revenue decline exemplifies the group's fragmentation. ### Related Stocks - [00142.HK](https://longbridge.com/en/quote/00142.HK.md) - [01661.HK](https://longbridge.com/en/quote/01661.HK.md) - [03848.HK](https://longbridge.com/en/quote/03848.HK.md) - [08021.HK](https://longbridge.com/en/quote/08021.HK.md) - [02360.HK](https://longbridge.com/en/quote/02360.HK.md) - [03179.HK](https://longbridge.com/en/quote/03179.HK.md) - [01901.HK](https://longbridge.com/en/quote/01901.HK.md) - [02177.HK](https://longbridge.com/en/quote/02177.HK.md) - [01541.HK](https://longbridge.com/en/quote/01541.HK.md) ## Related News & Research - [ImmuneOnco Issues Notice of Extraordinary General Meeting](https://longbridge.com/en/news/306151740.md) - [ImmuneOnco Files Next-Day Disclosure With HKEX Announcing Share Buyback](https://longbridge.com/en/news/306256889.md) - [ImmuneOnco Discloses Share Buyback in Next-Day HKEX Filing](https://longbridge.com/en/news/305690469.md) - [ImmuneOnco affiliate ImmuneCare attracts RMB 50 million in capital increase for 15.83% stake](https://longbridge.com/en/news/295152988.md) - [UNQ Holdings Subsidiary Guarantees Up to RMB 44.1 Million for Affiliate Shanghai Xuyi](https://longbridge.com/en/news/302861735.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**